Loading...
Loading...
India's nivolumab imports from UNITED STATES total $48.1B across 83 shipments from 12 foreign suppliers. SWORDS LABORATORIES UNLIMITED COMPANY leads with $48.1B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for nivolumab — a diversified sourcing base with multiple active suppliers from UNITED STATES.

SWORDS LABORATORIES UNLIMITED COMPANY is the leading Nivolumab supplier from UNITED STATES to India, with import value of $48.1B across 43 shipments. The top 5 suppliers — SWORDS LABORATORIES UNLIMITED COMPANY, CELGENE LOGISTICS SARL, ALMAC CLINICAL SERVICES, ESPEE BIOPHARMA & FINECHEM LLC, BIO-RAD ABD SEROTEC LTD, — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SWORDS LABORATORIES UNLIMITED COMPANY | $48.1B | 43 | 100.0% |
| 2 | CELGENE LOGISTICS SARL | $6.1M | 1 | 0.0% |
| 3 | ALMAC CLINICAL SERVICES | $262.3K | 1 | 0.0% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $37.6K | 2 | 0.0% |
| 5 | BIO-RAD ABD SEROTEC LTD, | $20.6K | 15 | 0.0% |
| 6 | MS ESPEE BIOPHARMA & FINECHEM LLC | $9.3K | 2 | 0.0% |
| 7 | MS NEWLIFE MEDICALS (USA).INC. | $5.2K | 1 | 0.0% |
| 8 | PIERCE BIOTECHNOLOGY,INC. | $4.0K | 8 | 0.0% |
| 9 | NEW LIFE MEDICALS (USA) INC. | $3.5K | 1 | 0.0% |
| 10 | LIFE TECHNOLOGIES LIMITED | $1.8K | 7 | 0.0% |
| 11 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $1.5K | 1 | 0.0% |
| 12 | TEVA BRANDED PHARMACEUTICAL PRODUCT | $50 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED | $48.1B | 39 | 100.0% |
| 2 | BRISTOL MYERS SQUIBB INDIA PRIVATE LIMITED | $6.1M | 1 | 0.0% |
| 3 | BRISTOL-MYERS SQUIBB INDIA PVT. LTD. | $2.6M | 3 | 0.0% |
| 4 | BRISTOL-MYERS SQUIBB INDIA PVT LTD | $2.1M | 1 | 0.0% |
| 5 | NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED | $262.3K | 1 | 0.0% |
| 6 | BIOCON BIOLOGICS LIMITED | $34.1K | 1 | 0.0% |
| 7 | BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED | $20.6K | 15 | 0.0% |
| 8 | MSN LABORATORIES PRIVATE LIMITED | $10.8K | 3 | 0.0% |
| 9 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $5.2K | 1 | 0.0% |
| 10 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $4.9K | 12 | 0.0% |
| 11 | INTAS PHARMACEUTICALS LIMITED | $4.5K | 4 | 0.0% |
| 12 | ZYDUS LIFESCIENCES LIMITED | $3.5K | 1 | 0.0% |
| 13 | ADGYL LIFESCIENCES PRIVATE LIMITED | $50 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Nivolumab suppliers from UNITED STATES to India include SWORDS LABORATORIES UNLIMITED COMPANY, CELGENE LOGISTICS SARL, ALMAC CLINICAL SERVICES. The leading supplier is SWORDS LABORATORIES UNLIMITED COMPANY with import value of $48.1B USD across 43 shipments. India imported Nivolumab worth $48.1B USD from UNITED STATES in total across 83 shipments.
India imported Nivolumab worth $48.1B USD from UNITED STATES across 83 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Nivolumab sourced from UNITED STATES include BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED, BRISTOL MYERS SQUIBB INDIA PRIVATE LIMITED, BRISTOL-MYERS SQUIBB INDIA PVT. LTD.. The largest buyer is BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED with $48.1B in imports across 39 shipments.
The total value of Nivolumab imports from UNITED STATES to India is $48.1B USD, across 83 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
83 Verified Shipments
12 suppliers, 13 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists